Quarterly report pursuant to Section 13 or 15(d)

Equity Offerings

v3.22.1
Equity Offerings
3 Months Ended
Mar. 31, 2022
Equity Offerings  
Equity Offerings

16. Equity Offerings

On December 6, 2021, the Company filed a prospectus supplement to its Form S-3 Registration Statement covering the sale of up to $44,925,000 of its common shares in an “at-the market” offering, which is ongoing. During the three months ended March 31, 2022, the Company sold an aggregate of 2,730,725 common shares under this prospectus and realized net proceeds of $15,547,815 in connection therewith. At March 31, 2022, $22,118,520 of common shares were available for future sale under the ongoing “at-the market” offering.